Agilent Technologies, Inc. - A Sotuvning operatsion marjasi

Agilent Corp - A emitenti grafik logotipi

Agilent Technologies kompaniyasining noyob patentlari va dasturiy ta'minoti raqobatchilar uchun kirishning sezilarli to'siqlarini yaratadi, bu esa qimmat, ammo sinchkovlik bilan yetkazib beriladigan aniqlik uskunalari orqali yanada mustahkamlanadi. Asosiy biznes marjalaridagi o'zgarishlar ushbu samaradorlikni aniq tasdiqlaydi, bunda 24.10 darajasi joriy qiymatni ifodalaydi. Shu bilan birga, biznes biotexnologiya laboratoriyalarining kapital xarajatlariga tayanadi va barqaror servis shartnomalari orqali potentsial pasayishlarni qoplaydi.

A: agilent.com Sotuvning operatsion rentabelligi 04.07.2022 - 19.11.2026

agilent.com - tahliliy kesimlar va asosiy koʻrsatkichlar (A)

- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning umumiy tahlili:A, agilent.com
Agilent Technologies tayyor mahsulotlari

Operatsion marja qarz majburiyatlari va soliqlarni hisobga olguncha, asosiy biznes operatsiyalaridan olingan foyda ulushini aniqlash orqali xarajatlarni boshqarish samaradorligini o'lchaydi. Operatsion marjani tahlil qilish orqali investor Agilent Technologies (A) kompaniyasining barqarorligini baholaydi, bu esa tibbiy uskunalarning neytral geosiyosiy maqomi bilan ta'minlanib, hatto global beqarorlik sharoitida ham barqaror pul oqimi va kapital himoyasini kafolatlaydi.

Agilent Technologies raqobatchilari

Sotuvning operatsion marjasi DGX|Sotuvning operatsion marjasi Illumina Corp (ILMN)|Sotuvning operatsion marjasi EXAS (Exact Sciences)|Operatsion foyda koeffitsiyenti RVTY|Bio-Rad - Sotuvning operatsion marjasi|Anbio - Operatsion rentabellik|soterahealth.com - Operatsion marja|Operatsion foyda normasi QDEL (QuidelOrtho)|OPK (OPKO Corp) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha sotuv rentabelligi CDNA|MRVI (Maravai LifeSciences Holdings) - Operatsion marja|Sotuvning operatsion rentabelligi Fulgent Genetics Inc FLGT|Operatsion rentabellik fluidigm.com (LAB)|Sotuvning operatsion marjasi Cytek Bio CTKB|Operatsion marja OSUR (OraSure Technologies)|Operatsion foyda bo'yicha marjinallik Exagen Inc.|MDXH - Operatsion rentabellik|Operatsion faoliyat rentabelligi Lucid Diagnostics Inc LUCD|PRE: Operatsion marja|Insight Molecular (IMDX) - Operatsion marja|TRIB (trinitybiotech.com) - Operatsion marja|prophaselabs.com (PRPH) - Operatsion faoliyat rentabelligi|Operatsion marja AIMD|Operatsion faoliyat rentabelligi Co-Diagnostics Inc|Operatsion marja HSCS (Heart Test Laboratories, Inc.)|Operatsion foyda normasi BMRA|CDIO - Operatsion rentabellik|Sotuvning operatsion rentabelligi onconetix.gcs-web.com|Virax Biolabs Group (VRAX) - Operatsion rentabellik|BJDX - Operatsion faoliyat rentabelligi|AWH (Aspira Women's Health, Inc.) - Operatsion marja|Accelerate Diagnostics, Inc (AXDX) - Operatsion faoliyat rentabelligi|Operatsion marja CNTG|ENZ - Sotuvning operatsion rentabelligi|Operatsion foyda normasi Fresh2 Group Ltd|Genetic Technologies (GENE) - Sotuvning operatsion rentabelligi|ME - Operatsion rentabellik|Operatsion faoliyat rentabelligi Psychemedics Corp PMD